ANNE C. WHITAKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LISATA THERAPEUTICS, INC.

Filing Date Source Excerpt
2021-04-28 Anne C. Whitaker joined the Caladrius Board in November 2020. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Ms. Whitaker. ... The Science and Technology Committee consists of Drs. Davidson (Chairman), Brown, Traber, Mazzo, Mr. Klosk, Ms. Schwalm and Ms. Whitaker. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2020. ... Anne Whitaker $8,371 Fees Earned in Cash, $120,000 Stock Awards, $0 Option Awards, $128,371 Total Compensation.

MADRIGAL PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2015-04-30 Ms. Whitaker earned her B.S. in Chemistry and Business from the University of North Alabama.

ORASURE TECHNOLOGIES INC

Filing Date Source Excerpt
2022-04-07 Ms. Whitaker is a seasoned healthcare executive and director with over 30 years of experience. She holds a B.S. in chemistry and has held executive roles in pharmaceutical companies.

WOLFSPEED, INC.

Filing Date Source Excerpt
2014-09-09 Anne C. Whitaker. Chief Executive Officer and President of Synta Pharmaceuticals Corp. Cree Director since 2013. The members of the Governance and Nominations Committee are Messrs. Ingram, Hosein, Plastina, Replogle, Tillman, Werner and Ms. Whitaker. The members of the Compensation Committee are Messrs. Werner and Tillman and Ms. Whitaker.
2015-09-08 Anne C. Whitaker. Executive Vice President and Company Group Chairman of Valeant Pharmaceuticals International, Inc. Cree Director since 2013.
2016-09-06 Anne C. Whitaker. Executive Vice President and Company Group Chairman of Valeant Pharmaceuticals International, Inc. Cree Director since 2013.
2017-09-08 Anne C. Whitaker. Chief Executive Officer and President of Novoclem Therapeutics. Cree Director since 2013.
2018-09-07 The members of the Compensation Committee during fiscal 2018 were Messrs. Nye and Werner and Ms. Whitaker. ... Director Compensation for Fiscal 2018: Anne C. Whitaker Fees Earned or Paid in Cash $75,000, Stock Awards $171,676, Total $246,676.
2019-09-10 Anne C. Whitaker (10) $75,000 Fees Earned or Paid in Cash, $171,560 Stock Awards, Total $246,560. Ms. Whitaker is a member of the Compensation Committee and Nomination and Governance Committee.
2020-09-09 Ms. Whitaker has been a member of the Board of Directors since December 2013. ... The members of the Governance and Nominations Committee during fiscal 2020 were Messrs. Hodge, Hosein, Jackson, Replogle, and Werner and Mses. Dorchak, Le and Whitaker. ... The members of the Compensation Committee during fiscal 2020 were Mr. Werner and Mses. Dorchak, Le and Whitaker.

Data sourced from SEC filings. Last updated: 2026-02-03